Evolent Health (EVH) Stock Price, News & Analysis

Company Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Key Stats

• Today's Range: $24.41 to $26.28
• 50-Day Range: $24.96 to $32.96
• 52-Week Range: $17.98 to $35.00
• Volume: 3.15 million shs
• Average Volume: 1.61 million shs
• Market Capitalization: $2.90 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $39.30
• Consensus Rating: Buy

Evolent Health Stock Analysis - MarketRank™

Evolent Health scored higher than 82% of companies evaluated by MarketBeat, and ranked 181st out of 658 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.5 / 5
• Analyst Rating: Buy

Consensus Rating

Evolent Health has received a consensus rating of Buy. The company's average rating score is 3.08, and is based on 11 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Evolent Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 23.26%

Earnings Growth

Earnings for Evolent Health are expected to grow by 23.26% in the coming year, from $0.86 to $1.06 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Evolent Health is -26.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Evolent Health is -26.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Evolent Health has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

10.78% of the outstanding shares of Evolent Health have been sold short.

Short Interest Ratio / Days to Cover

Evolent Health has a short interest ratio ("days to cover") of 5.4.

Change versus previous month

Short interest in Evolent Health has recently decreased by 10.75%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Evolent Health does not currently pay a dividend.

Dividend Growth

Evolent Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

10.78% of the outstanding shares of Evolent Health have been sold short.

Short Interest Ratio / Days to Cover

Evolent Health has a short interest ratio ("days to cover") of 5.4.

Change versus previous month

Short interest in Evolent Health has recently decreased by 10.75%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.80

News Sentiment

Evolent Health has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for Evolent Health this week, compared to 4 articles on an average week.

Search Interest

Only 1 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

MarketBeat Follows

6 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,290,385.00 in company stock.

Percentage Held by Insiders

Only 1.60% of the stock of Evolent Health is held by insiders.

EVH Stock Analysis - Frequently Asked Questions

How have EVH shares performed this year?

Evolent Health's stock was trading at $33.03 at the start of the year. Since then, EVH stock has decreased by 24.4% and is now trading at $24.96.
View the best growth stocks for 2024 here.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) issued its quarterly earnings results on Thursday, August, 8th. The technology company reported $0.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.21 by $0.09. Evolent Health's revenue for the quarter was up 37.9% compared to the same quarter last year.

When did Evolent Health IPO?

Evolent Health (EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Top institutional shareholders of Evolent Health include Creative Planning (0.04%), SG Americas Securities LLC (0.03%), ERn Financial LLC (0.03%) and Park Avenue Securities LLC (0.01%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Emily Ann Rafferty, Diane Holder, Cheryl Scott, Mary Bridget Duffy and Steve Tutewohl.
View institutional ownership trends.

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

• Last Earnings: 8/08/2024
• Today: 10/17/2024
• Next Earnings (Confirmed): 11/07/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Computer and Technology
• Industry: Management services
• Sub-Industry: Business Services
• Current Symbol: NYSE:EVH
• CUSIP: N/A
• CIK: 1628908
• Web: www.evolenthealth.com
• Phone: (571) 389-6000
• Fax: 571-389-6001
• Employees: 4,700
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $39.30
• High Stock Price Target: $45.00
• Low Stock Price Target: $31.00
• Potential Upside/Downside: +57.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.08
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($1.25)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 29.02
• P/E Growth: N/A
• Net Income: $-113,040,000.00
• Net Margins: -3.16%
• Pretax Margin: -4.01%
• Return on Equity: 8.47%
• Return on Assets: 3.45%

Debt

• Debt-to-Equity Ratio: 0.57
• Current Ratio: 1.08
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: $2.35 billion
• Price / Sales: 1.23
• Cash Flow: $1.70 per share
• Price / Cash Flow: 14.71
• Book Value: $9.38 per share
• Price / Book: 2.66

Miscellaneous

• Outstanding Shares: 116,213,000
• Free Float: 114,429,000
• Market Cap: $2.90 billion
• Optionable: Optionable
• Beta: 1.56